2021 Volume 18 Issue 2 Pages 304-313
At the present with the coming unprecedented ageing society in Japan, sarcopenia accompanied with aging is one of the crucial points to decide the treatment strategy for the patients with gastrointestinal cancer. In this section, we retrospectively evaluated supporting evidence including our studies to clarify the prognostic impact of myopenia or myosteatosis, the prognostic impact of postoperative infectious complication, and correlation between alteration of body composition and postoperative infectious complication, to discuss future perspective for these points in patients with gastrointestinal cancer.
